Welcome. We are iOmx

iOmx is a clinical-stage biotech company that harnesses deep tumor immunology insights to generate novel treatments for the most prevalent solid tumor indications. The company is translating unexplored immune evasion biology into a growing pipeline of biomarker-enabled drug programs.

iomx_we-are-iomx
On the cutting edge of Biotech

Advancing the Next Generation of Immuno-Oncology Therapies

Our Pipeline
Science with Purpose

Driven by Impact

Driving Impact Investors

Learn More

Your next big Career step.

Work at iOmx